The firm has revealed the extent of the win seen in the ACACIA-HCM study in patients with symptomatic non-obstructive ...
Adapting to the challenges of Most Favored Nation pricing is a top priority in biopharma boardrooms, though the pricing gulf ...
Combining long reads with AI, pangenome references and diploid assembly could dramatically improve genetic disease diagnosis, ...
Axendia: 63% Of Life Science Pros Expect AI Spending To Rise In 2027 Despite ‘Poor’ Data Quality
A survey of 194 life sciences and medtech professionals showed that 63% expect AI investments to rise in 2027 with the ...
Japan's latest batch of approval recommendations include global-first nods for anselamimab for kappa light chain amyloidosis ...
The FDA approval of Gilead’s once-daily combination of bictegravir and lenacapavir opens a new option for the minority of ...
The FDA has selected Epitel's wearable EEG system and Prapela's infant cardiac device as the first participants in its ...
A Pew survey of 3,488 US adults finds 72% want to be told if AI is used in their care and 46% do not know if it has already ...
The FDA approved the oral suspension tablet formulation of Tivicay for children from 4 weeks of age to under 6 years, a ...
Adverse event reports for at least 30 patients come as FDA considers whether to make additional peptides available to ...
Target is rolling out Target Beauty Studio, a curated assortment of prestige brands in more than 600 Target stores.
The obesity drug is available through a short-term Medicare demonstration project called the GLP-1 Bridge, but CMS is looking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results